Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,851 across all filing types
Latest filing 2021-09-30 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
第五届董事会第十四次（临时）会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions from the company's fifth board of directors' fourteenth (extraordinary) meeting. It discusses adjustments to a major asset restructuring and related transactions, including changes to the transaction price, payment methods, performance commitments, and other terms. The document includes voting results, mentions the need for shareholder approval, and references related reports and audit opinions. It is not a full annual or interim report, nor is it a simple announcement of a report publication. It is not a call transcript, earnings release, or remuneration report. The content focuses on board decisions and management-level approvals regarding a significant transaction and related agreements. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by the board or senior management, especially regarding major transactions and corporate actions.
2021-09-30 Chinese
关于参加2021年度青岛辖区上市公司投资者网上集体接待日公告
Regulatory Filings Classification · 95% confidence The document is an announcement about the company's participation in an investor online collective reception day organized by regulatory and industry bodies. It mentions the date and time of the event and the participation of senior management for communication with investors. There is no financial data, no report attached or published, and no mention of voting results or changes in management. The document is a regulatory announcement related to investor relations and communication, not a financial report or meeting materials. Given the short length and nature of the content, it fits best under Regulatory Filings (RNS).
2021-09-17 Chinese
关于出售长春盈康医院有限公司100%股权及相关债权暨关联交易的进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding the progress of a transaction involving the sale of 100% equity and related debt of a subsidiary company. It details the approval of the transaction by the board and shareholders, the signing of agreements, completion of registration, and payment obligations. The document does not contain financial statements or detailed financial analysis but serves as an update on a capital transaction and related corporate actions. It is not a full financial report, earnings release, or regulatory certification. Given the content focuses on a transaction update and progress announcement, the most appropriate classification is Capital/Financing Update (CAP). The document length is short and it is not merely announcing a report publication, so it is not RPA or RNS.
2021-09-14 Chinese
关于出售杭州怡康中医肿瘤医院有限公司100%股权及相关债权暨关联交易的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of a transaction involving the sale of 100% equity and related debt of a subsidiary company. It details the approval of the transaction by the board and shareholders, the signing of the transfer agreement, completion of registration, and payment terms. There is no financial report or detailed financial data presented, nor is it a regulatory certification or a voting result announcement. The document is a corporate announcement about a capital transaction progress, specifically a sale of equity and related debt, which fits best under Capital/Financing Update (CAP). The document length is short and it is not a report publication announcement or regulatory filing. Therefore, the classification is CAP with high confidence.
2021-09-13 Chinese
关于完成工商变更登记的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the completion of a business registration change, specifically the appointment of a new general manager and legal representative, and the update of the business license. It references a prior board meeting resolution and provides details of the change in legal representative. There is no financial data, no report attached or referenced as being published, and no mention of financial results or regulatory filings beyond this management change. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2021-09-13 Chinese
关于重大资产重组事项的进展公告
Capital/Financing Update Classification · 95% confidence The document is a progress announcement regarding a major asset restructuring (重大资产重组事项的进展公告) by 盈康生命科技股份有限公司. It details the ongoing acquisition process, historical disclosures, approvals, and risk warnings related to the transaction. The document is about the progress and updates of a major asset restructuring, not the full transaction report itself. It is relatively short (3759 characters) and serves as an update rather than a comprehensive report. Therefore, it fits best into the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as major asset acquisitions.
2021-09-08 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.